Global Biosimilar Therapeutic Peptides Market Value Expected To Reach $1.72 Billion By 2023

Global Biosimilar Therapeutic Peptides Market Value Expected To Reach $1.72 Billion By 2023

“Biosimilar Therapeutic Peptides Global Market Report 2020-30: Covid 19 Growth And Change”
Eli Lilly Is One Of The Largest Players In The Biosimilar Therapeutic Peptides Market, According To The Business Research Company’s Biosimilar Therapeutic Peptides Global Market Report 2020-30: Covid 19 Growth And Change

(Companies Covered: Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG, Novo Nordisk A/S, Ipsen S.A, Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Bachem Holding AG, CordenPharma International, BioPartners, Hyperion Therapeutics, PeptiDream, Bachem Holding AG, Lonza Inc., Bristol-Myers Squibb(BMS), PolyPeptide Laboratories.)

The global biosimilar therapeutic peptides market is expected to decline from $0.80 billion in 2019 to $0.77 billion in 2020 at a compound annual growth rate of -3.45%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $1.72 billion in 2023 at a compound annual growth rate of of 30.48%.

Read More On The Global Biosimilar Therapeutic Peptides Market Report At –

https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptides-global-market-report-2020-30-covid-19-growth-and-change

The biosimilar therapeutic peptides market consists of sales of biosimilar therapeutic peptides by the companies that are engaged in developing and commercialization of biosimilar peptides drugs for therapeutic applications. Peptide drugs are used as replacement therapies, which supplement peptide hormones when the endogenous levels tend to decrease. Biosimilar therapeutic peptides are used in the treatment of cardiovascular diseases, metabolic diseases, respiratory conditions, cancer, and respiratory diseases.

Global Biosimilar Therapeutic Peptides Market Segmentation –

1) By Route Of Administration: Parenteral Route, Transdermal Route, Others

2) By Application: Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders

Global Biosimilar Therapeutic Peptides Market Driver –

Biosimilar therapeutic peptides are used for the treatment of various chronic diseases and cancer. The expected increase in the aging population suffering from various chronic conditions will drive the biosimilar therapeutic peptides market.

Request For A Sample Of The Global Biosimilar Therapeutic Peptides Market Report At –

https://www.thebusinessresearchcompany.com/sample.aspx?id=3423&type=smp

Few Points From The Global Biosimilar Therapeutic Peptides Market TOC

1. Executive Summary

2. Biosimilar Therapeutic Peptides Market Characteristics

3. Biosimilar Therapeutic Peptides Market Size And Growth

3.1. Global Biosimilar Therapeutic Peptides Historic Market, 2015 – 2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Biosimilar Therapeutic Peptides Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Biosimilar Therapeutic Peptides Market Segmentation

4.1. Global Biosimilar Therapeutic Peptides Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

4.2. Global Biosimilar Therapeutic Peptides Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5. Biosimilar Therapeutic Peptides Market Regional And Country Analysis

5.1. Global Biosimilar Therapeutic Peptides Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5.2. Global Biosimilar Therapeutic Peptides Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Media Contact
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
Address:
City: London
State: Greater London
Country: United Kingdom
Website: https://www.thebusinessresearchcompany.com/